EM-T3Expert Opinion on Drug Safety2023-05-17第 22 卷第 9 期，819-832开放获取
Safety and effectiveness of empagliflozin in clinical practice as monotherapy or with other glucose-lowering drugs in Japanese patients with type 2 diabetes: subgroup analysis of a 3-year post-marketing surveillance study
